SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-017704
Filing Date
2021-01-26
Accepted
2021-01-26 16:13:01
Documents
15
Period of Report
2021-01-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d102158d8k.htm   iXBRL 8-K 26563
2 EX-5.1 d102158dex51.htm EX-5.1 9200
3 EX-1.1 d102158dex11.htm EX-1.1 179861
7 GRAPHIC g102158g98e47.jpg GRAPHIC 2238
  Complete submission text file 0001193125-21-017704.txt   391638

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pgen-20210121.xsd EX-101.SCH 3054
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pgen-20210121_lab.xml EX-101.LAB 17373
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pgen-20210121_pre.xml EX-101.PRE 10942
8 EXTRACTED XBRL INSTANCE DOCUMENT d102158d8k_htm.xml XML 3222
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Filer) CIK: 0001356090 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36042 | Film No.: 21554198
SIC: 2834 Pharmaceutical Preparations